Loading clinical trials...
Loading clinical trials...
Entecavir Intensification for Persistent Hepatitis B Virus (HBV) Viremia in HIV-HBV Infection
Conditions
Interventions
Entecavir with continued standard of care antiretroviral therapy
continued standard of care with tenofovir in addition to emtricitabine or lamivudine
Locations
1
United States
San Francisco General HIV Clinical Trials Group
San Francisco, California, United States
Start Date
April 1, 2008
Primary Completion Date
February 1, 2010
Completion Date
May 1, 2010
Last Updated
May 27, 2013
NCT07024641
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT06665646
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions